Prophylaxis Regimen for Hemophilia A Patients

NCT05036278 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A
Prophylaxis of Bleeding

Interventions

BIOLOGICAL: Damoctocog alfa-pegol is a recombinant B-domain deleted human coagulation FVIII variant site specifically conjugated with a 60 kDa, branched (30 kDa each) polyethylene glycol (PEG).

Sponsor

Bayer